针对IBD治疗:用于口服的智能药物输送系统
Jiabin Xu1,2, Peiyu Tang1,2, Xiaoyi Sun1
1School of Stomatology, Xuzhou Medical University, Xuzhou, 221004, China.
Materials today. Bio
|January 26, 2026
概括
智能口服药物输送系统通过准特定部位,为炎症性肠病 (IBD) 提供了改进的治疗方法. 与传统疗法相比,这些先进的系统提高了疗效,减少了副作用.
科学领域:
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD) 是一种普遍存在的全球性疾病,影响患者的生活质量.
- 传统的IBD口服疗法面临着诸如针对性差,全身吸收和药物不稳定性等挑战,导致疗效降低和不良影响.
研究的目的:
- 审查和讨论用于IBD治疗的智能口服药物输送系统的设计.
- 突出这些先进交付平台的机制,优势和挑战.
主要方法:
- 对刺激反应药物递送机制 (内部和外部触发器) 的审查.
- 对IBD智能输送系统的临床前研究结果的分析.
主要成果:
- 智能药物输送系统利用内部 (pH,ROS,酶) 和外部 (磁场,光) 刺激,实现精确的局部药物释放.
- 这些系统在增强治疗疗效,最大限度地减少全身毒性和改善患者服药性方面显示出潜力.
- 临床前研究表明,延长缓解和促进IBD的粘膜愈合有希望.
结论:
- 智能口服药物输送系统是克服传统IBD疗法的局限性的有希望的策略.
- 需要进一步的研究来优化配方,临床验证,并解决成功临床转换的患者间变异性.
- 持续开发对于优化这些先进平台以有效管理IBD至关重要.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
483
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
483
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
462
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
462
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
516
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
516
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
524
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
524
Additional Routes of Drug Administration
4.7K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
4.7K
Routes of Drug Administration: Enteral
6.4K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
6.4K


